Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer

Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer

Non-small-cell lung cancer (NSCLC) is one of the most common malignancies, and specific molecular targets are still lacking. Angiogenesis plays a central regulatory role in the growth and metastasis of malignant tumors and angiogenic factors (AFs) are involved. Although there are many studies compar...

Full description

Bibliographic Details
Main Authors: Xinpei Gu, Liuxi Chu, Yanlan Kang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Genetics
Subjects:
NSCLC
angiogenic factors
immunotherapy response
model validation
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.894024/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.894024/full

Similar Items